Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic effect and quadriceps strength with 0.1% vs 0.2% ropivacaine femoral nerve block after knee arthroscopy
ChiCTR2000041404Phase 4Completed
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in meniscal tear (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: numeric rating scale pain score and quadriceps muscle strength. Started Jul 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
meniscal tear
Beyond the preview
Go deeper on ChiCTR2000041404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041404.